BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26319975)

  • 21. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock.
    Tsujimoto H; Ono S; Hiraki S; Majima T; Kawarabayashi N; Sugasawa H; Kinoshita M; Hiraide H; Mochizuki H
    J Endotoxin Res; 2004; 10(4):229-37. PubMed ID: 15373966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
    Shoji H; Tani T; Hanasawa K; Kodama M
    Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
    Fujimori K; Tarasawa K; Fushimi K
    Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.
    Cruz DN; Antonelli M; Fumagalli R; Foltran F; Brienza N; Donati A; Malcangi V; Petrini F; Volta G; Bobbio Pallavicini FM; Rottoli F; Giunta F; Ronco C
    JAMA; 2009 Jun; 301(23):2445-52. PubMed ID: 19531784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
    Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
    Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
    Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
    Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
    J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.
    Vincent JL; Laterre PF; Cohen J; Burchardi H; Bruining H; Lerma FA; Wittebole X; De Backer D; Brett S; Marzo D; Nakamura H; John S
    Shock; 2005 May; 23(5):400-5. PubMed ID: 15834304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymyxin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry.
    Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group
    Blood Purif; 2014; 37 Suppl 1():22-5. PubMed ID: 24457492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
    Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
    Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.
    Ichiyasu H; Horio Y; Masunaga A; Migiyama Y; Sakamoto Y; Jodai T; Ideguchi H; Okabayashi H; Hamada S; Yoshida C; Hirosako S; Okamoto S; Kohrogi H
    Ther Adv Respir Dis; 2017 Jul; 11(7):261-275. PubMed ID: 28554260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
    Kanesaka S; Sasaki J; Kuzume M; Narihara K; Takahashi Y
    Int J Artif Organs; 2008 Oct; 31(10):891-7. PubMed ID: 19009507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
    Maekawa H; Negishi K
    Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
    Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M
    Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.